Belvedere Trading »

Acumen Pharmaceuticals shares owned by Belvedere Trading

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2023-06-30 $73k 15k 4.81

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Strategy Cl A New (MSTR)
Apple (AAPL)
Broadcom (AVGO)
Spdr Gold Tr Gold Shs Call Option (GLD)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Amazon (AMZN)
Advanced Micro Devices (AMD)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Palantir Technologies Cl A (PLTR)

View all positions for Belvedere Trading

Top funds holding Acumen Pharmaceuticals

RA Capital Management
Sands Capital Ventures
Franklin Resources
FMR
Vanguard Group
Knollwood Investment Advisory
Alyeska Investment Group
ADAR1 Capital Management
Laurion Capital Management
Pathstone Holdings
Hudson Bay Capital Management
Millennium Management
Renaissance Technologies
Citadel Advisors
Two Sigma Advisers

View all funds holding Acumen Pharmaceuticals